Current use of ophthalmic beta blockers

Journal of Glaucoma

Volumn 6, Issue 3, 1997, Pages 188-191

  Gross, Ronald L ^a   Pineyro, Alfredo ^a  

^a CULLEN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARTEOLOL; LEVOBUNOLOL; METIPRANOLOL; TIMOLOL; TIMOLOL MALEATE;

DRUG EFFICACY; DRUG SAFETY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT; TOPICAL DRUG ADMINISTRATION;

EID: 0030850009     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-199706000-00009     Document Type: Short Survey

References (29)

1. Doane MG. Blinking and the mechanics of lacrimal drainage system. Ophthalmology 1981;88:844-51.
2. Zimmerman TJ, Kooner KS, Kandarakis AS, Ziegler, LP. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol 1984;102:551.
3. Boger WP III. Timolol: Short term "escape" and long term "drift". Ann Ophthalmol 1979;11:1239.
4. Harris A, Spaeth GL, Sergott RC, et al. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma. Am J Ophthalmol 1995;120:168-75.
5. Kaiser HJ, Flammer J, Messmer C, et al. Thirty-month visual field follow-up of glaucoma patients treated with beta-blockers. J Glaucoma 1992;1:153-55.
6. Levobunolol Study Group T. Levobunolol: A beta adrenoceptor antagonist effective in the long-term treatment of glaucoma. Ophthalmology 1985;92:1271-6.
7. Serle JB, Lustgarten JS, Podos SM. A clinical trial of metipranolol, a noncardioselective beta-adrenergic antagonist in ocular hypertension. Am J Ophthalmol 1991;112:302-7.
8. Secoville B, Mueller B, White BG, Krieglestein GK. A double-masked comparison of carteolol and Timolol in ocular hypertension. Am J Ophthalmol 1988;105:150-4.
9. Berry DP, Van Buskirk EM, Shields MB. Betaxolol and Timolol: a comparison of efficacy and side effects. Arch Ophthalmol 1984; 102:42-5.
10. Allen RC, Epstein DL. Additive effect of betaxolol and epinephrine in primary open-angle glaucoma. Arch Ophthalmol 1986;104: 1178.
11. Dailey RA, Brubaker RF, Bourne WM. The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal subjects. Am J Ophthalmol 1982;93:232-7.
12. Coakes RL, Brubaker RS. The mechanism of timolol in lowering intraocular pressure. Arch Ophthalmol 1978;96:2045-8.
13. Reiss GR, Lee DA, Topper JE, Brubaker RF. Aqueous humor flow during sleep. Invest Ophthalmol Vis Sci 1984;25:776-8.
14. Fraunfelder FT, Meyer SM. Systemic adverse reactions to glaucoma medications [Review]. Int Ophthalmol Clin 1989;29:143-6.
15. Van Buskirk EM, Fraunfelder FT. Ocular beta blockers and systemic effects. Am J Ophthalmol 1984;98:623-4.
16. Van Buskirk EM. Adverse reactions from timolol administration. Ophthalmology 1980;87:447-50.
17. Fraunfelder FT, Meyer SM, Menacker SJ. Alopecia possibly secondary to topical ophthalmic beta-blockers [Letter]. JAMA 1990; 263:1493-4.
18. Lynch MG, Whitson JT, Brown RH, Nguyen H, Drake MM. Topical betablocker therapy and central nervous system side effects: a preliminary study comparing betaxolol and timolol. Arch Ophthalmol 1988;106:908-11.
19. Schoene RB, Abuan T, Ward RL, Beasley CH. Effects of topical betaxolol, timolol and placebo on pulmonary function in asthmatic bronchitis. Am J Ophthalmol 1984;97:86-92.
20. Van Buskirk EM, Weinreb RN, Berry DP, Lustgarten JS, Podos SM, Drake MM. Betaxolol in patients with glaucoma and asthma. Am J Ophthalmol 1986;101:531-4.
21. Weinreb RN, Van Buskirk EM, Cherniack R, Drake M. Long term betaxolol therapy in glaucoma patients with pulmonary disease. Am J Ophthlamol 1988;106:162-7.
22. Van Buskirk EM. Corneal anesthesia after timolol maleate therapy. Am J Ophthalmol 1979;88:739-43.
23. Wilhelmus KR, McCulloch RR, Gross RL. Dendritic keratopathy associated with beta-blocker eyedrops. Cornea 1990;9:335-7.
24. Velde TM, Kaiser FE. Ophthalmic timolol treatment causing altered hypoglycemic response in a diabetic patient. Arch Intern Med 1983;143:1627.
25. Coppeto JR. Timolol associated myasthenia gravis. Am J Ophthalmol 1984;98:244-5.
26. Olson RJ, Bromberg BB, Zimmerman TJ. Apneic spells associated with timolol therapy in a neonate. Am J Ophthalmol 1979;88: 120-2.
27. Coleman AL, Diehl DLC, Jampel HD, Bachorik PS, Quigley HA. Topical timolol decreases plasma high density lipoprotein cholesterol level. Arch Ophthalmol 1990;108:1260-3.
28. Freedman SF, Freedman NJ, Shields MB, et al. Effects of ocular carteolol and timolol on plasma high density lipoprotein cholesterol level. Am J Ophthalmol 1993;116:600-1.
29. Stewart WC. Carteolol, an ophthalmic beta-blocking agent with intrinsic sympathomimetic activity. J Glaucoma 1994;3:339-45.